Abstract |
Although feasibility and efficacy of percutaneous tricuspid valve-in-valve implantation have been established, a transtricuspid pacing or defibrillator lead might preclude this technique: lead damage can cause lead dysfunction resulting in inappropriate or inefficient pacing or shocks. In these cases, lead removal is thought to be the only option. We describe a patient who presented with rapid clinical deterioration due to tricuspid valve stenosis early after implantation of an internal defibrillator with a transvalvular shock-lead. A transvenous valve-in-valve implantation of the tricuspid valve was performed after protecting the defibrillator-lead with a custom-made covered stent. We describe the technical issues, the clinical outcome, and the evolution of lead function after implantation.
|
Authors | Pieter De Meester, Werner Budts, Marc Gewillig |
Journal | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
(Catheter Cardiovasc Interv)
Vol. 84
Issue 7
Pg. 1148-52
(Dec 01 2014)
ISSN: 1522-726X [Electronic] United States |
PMID | 24677782
(Publication Type: Case Reports, Journal Article)
|
Copyright | © 2014 Wiley Periodicals, Inc. |
Topics |
- Adult
- Angiography
- Catheterization, Central Venous
(methods)
- Defibrillators, Implantable
(adverse effects)
- Echocardiography, Doppler
- Follow-Up Studies
- Heart Valve Prosthesis Implantation
(methods)
- Humans
- Jugular Veins
- Male
- Tachycardia, Ventricular
(therapy)
- Tricuspid Valve Stenosis
(diagnosis, etiology, surgery)
|